Covovax | Zee News

Advertisement

Covovax News

25 Jun 2022

Govt panel recommends emergency approval of SII’s Covovax for 7-11 year-olds

"The Subject Expert Committee of Drugs Controller General Of India (DCGI) has recommended Serum Institute of India`s (SII) vaccine Covovax for children in the age group of 7-11 years," sources said.

03 May 2022

Fourth wave: SII slashes price of each dose of Covovax jab, check details

SII has slashed the price of each dose of Covovax The price of each dose anti-Covid jab has been slashed from Rs 900 to Rs 225 SII CEO has said that Covovax is now available for children in India

29 Apr 2022

NTAGI approves SII's covid vaccine Covovax for 12-17 age group: Sources

The National Technical Advisory Group on Immunization (NTAGI) on Friday approved Serum Institute of India's Covid-19 vaccine Covovax for the 12-17 age group, as per ANI.

04 Apr 2022

Covovax makes it to Covid vaccine basket, proposed for all kids above 12

Covovax was approved by India's drug regulator for restricted use in emergency situations in adults on December 28. India began inoculating children aged 12-14 from March 16. Biological E's Corbevax is being used to inoculate them.

COVID-19 booster shot

23 Mar 2022

Covovax as booster dose: DCGI gives nod to phase-3 clinical trials

The vaccine has not been included in the country's inoculation programme against Covid-19 Covovax is manufactured by technology transfer from Novavax and is approved by European Medicines Agency for conditional marketing authorisation Many countries have been administering booster doses to their citizens, considering the uncertainties of the pandemic.

23 Mar 2022

Novovax Covid-19 vaccine gets EUA nod for those aged between 12-18 yrs

According to an official statement released by Novovax, the vaccine, also known as NVX-CoV2373, is manufactured and marketed in India by the Serum Institute of India (SII) under the brand name Covovax and is the first protein-based vaccine authorized for use in this age group in India.

09 Mar 2022

SII's ‘Covovax’ gets emergency use nod for children aged above 12 years

"Novavax in global trials has demonstrated more than 90 per cent efficacy. Serum Institute of India`s brand Covovax has completed bridging studies in India and has been granted Emergency Use Authorisation by DCGI for adults and for children above the age of 12. Younger age groups will follow shortly," SII CEO Adar Poonawala said in a tweet.

COVID-19 vaccine

04 Mar 2022

Covid-19 vaccine for 12-17 age group: Govt panel recommends EUA for Covovax

Covovax is Serum Institute of India's Covid-19 vaccine The recommendation of the Subject Expert Committee will be sent to the DCGI for approval India has so far been using Bharat Biotech's Covaxin to vaccinate adolescents between 15-18 years

21 Feb 2022

Serum Institute seeks EUA for Covovax Covid-19 vaccine for 12-17 yrs age group

Covovax already has EUA for restricted use in emergency situations in adults on December 28 The government has not yet decided on vaccinating those aged below 15

29 Dec 2021

Corbevax, Covovax, Molnupiravir: All about India's 3 new COVID19 vaccines

Six COVID-19 vaccines - Serum Institute's Covishield, Bharat Biotech's Covaxin, Zydus Cadila's ZyCoV-D, Russia's Sputnik V and the US-made Moderna and Johnson and Johnson - had already received EUA from the Indian drug regulator earlier.

29 Dec 2021

Covovax authorisation is a vital step in India, says Novavax CEO

The Drugs Controller General of India (DCGI) has issued Emergency Use Authorization (EUA) for Covovax to prevent COVID-19 for adults 18 years old and above.

28 Dec 2021

Corbevax and Covovax Vaccine Approved

2 vaccines and 1 drug related to corona have been approved. The Corbevax and Covovax vaccines have been approved.

28 Dec 2021

India gets two more COVID-19 vaccines, CORBEVAX and COVOVAX receive EUA nod

Molnupiravir, an anti-viral drug, has also been approved for restricted use in an emergency situation.

Serum Institute of India

27 Dec 2021

CDSCO panel recommends emergency use authorisation for Covovax, Corbevax

The DCGI office had granted SII permission to manufacture and stock Covovax on May 17 The World Health Organisation had on December 17 issued emergency use listing for Covovax

18 Dec 2021

Covovax gets emergency use approval

In view of the increasing threat of Omicron, WHO has approved the vaccine for children, Covovax

Serum Institute of India

17 Dec 2021

WHO approves Serum Institute's COVID vaccine, Covovax

Adar Poonawalla announced the news on Twitter The vaccine is named CovovaxTM

28 Nov 2021

Covovax not approved in country of origin yet: Govt panel tells SII

The Serum Institute of India (SII) had put in an application to the Drugs Controller General of India (DCGI) in October for grant of market authorisation of Covovax for restricted use in emergency situations.

01 Oct 2021

Phase 2/3 trials of Covovax in children between age 7 and 11 begins in Pune

"Pune`s Bharati Vidyapeeth Medical College Hospital began phase 2/3 trials of Covovax in children between 7 and 11 years of age on Wednesday. Nine children have been enrolled for the trial here," said Dr Sanjay Lalwani.

21 Aug 2021

Serum Institute files for WHO Emergency Use Listing for its Covovax vaccine

Serum Institute of India has filed for WHO emergency use listing for its upcoming COVID vaccine Covovax. The WHO has accepted the application of the Pune-based pharmaceutical company. A pre-submission meeting was also held on August 10.

06 Aug 2021

Hope to launch Covovax vaccine for adults in October this year: SII CEO

Poonawala said he is hopeful that for adults Covovax will be launched in October, depending on DCGI approvals. It will be a two-dose vaccine and the price will be decided at the time of launch, he added. Poonawalla met Home Minister Amit Shah in Parliament and the meeting between the two lasted for 30 minutes.

Loading...

NEWS ON ONE CLICK